SEED THERAPEUTICS
Seed Therapeutics is a biotech company that focuses on harnessing and engineering molecules.
SEED THERAPEUTICS
Industry:
Biotechnology Medical Therapeutics
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.seedtherapeutics.com
Total Employee:
11+
Status:
Active
Contact:
1-646-859-2751
Email Addresses:
[email protected]
Technology used in webpage:
Wordpress Plugins Nginx Sitelinks Search Box GoDaddy DNS Google Analytics 4 WordPress 5.9 HubSpot CMS Hub Divi A3 Lazy Load
Similar Organizations
Azaya Therapeutics
Azaya Therapeutics is a biotechnology company developing therapies for cancer and other serious medical conditions.
OLIGONUCLEOTIDE THERAPEUTICS SOCIETY INC
Oligonucleotide Therapeutics Society is an nonprofit forum to foster academia and industry-based research and development.
Trishula Therapeutics
Trishula Therapeutics is a biotechnology company that focus on developing cancer medicines.
WRS Therapeutics
WRS Therapeutics is targeting the multi-billion dollar injectables market with large molecule drugs delivered orally.
Current Advisors List
Official Site Inspections
http://www.seedtherapeutics.com
- Host name: 23.185.0.3
- IP address: 23.185.0.3
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Seed Therapeutics"
Leadership - Seed Therapeutics
[email protected] . [email protected] . LEADERSHIP BIOS. Lan Huang, Ph.D. ... (LCIP), an externally focused organization to engage biotech and academic …See details»
Seed Therapeutics - Seed Therapeutics
Oct 26, 2023 Collaborating with an unparalleled team of world-leading experts in the Ubiquitin Proteasome System and the field of Targeted Protein Degradation.. SEED Therapeutics is advancing its groundbreaking Molecular Glues …See details»
Seed Therapeutics - Crunchbase Company Profile
Seed Therapeutics is a biotech company that focuses on harnessing and engineering molecules.See details»
Seed Therapeutics - LinkedIn
Seed Therapeutics | 1,686 followers on LinkedIn. Seed Therapeutics is pioneering the science of improving human health by creating “molecular glues”: novel therapeutics that degrade disease ...See details»
Seed Therapeutics, Inc. - Drug pipelines, Patents, Clinical ... - Patsnap
Www.seedtherapeutics.com. Subsidiary Company | 2019 | New York, United States | 10-50 | www.seedtherapeutics.com. Last update 01 Nov 2024. Overview. Pipeline. Deal. Translational …See details»
Seed Therapeutics - PitchBook
Seed Therapeutics General Information Description. Developer of medical drugs intended to treat severe diseases. The company specializes in research and development and is engaged in …See details»
BeyondSpring Subsidiary, Seed Therapeutics, Announces Research ...
To learn more about Seed Therapeutics, please visit us at seedtherapeutics.com.About BeyondSpring Headquartered in New York, BeyondSpring is a global, clinical-stage …See details»
Bios - Seed Therapeutics
[email protected] ... (LCIP), an externally focused organization to engage biotech and academic collaborators in China. Prior to Lilly, Dr. Lin led the Chemistry Service Unit at WuXi AppTec, after leading multiple drug discovery …See details»
SEED Therapeutics, BeyondSpring Subsidiary, Appoints Jackson Tai …
Jun 20, 2023 Former Director at Eli Lilly, HSBC and Mastercard . Brings Almost Five Decades of Experience in Finance, Strategy and Risk Governance. NEW YORK, June 20, 2023 – SEED …See details»
Seed Therapeutics Launches Protein Degradation Research …
Oct 14, 2020 [email protected]@seedtherapeutics.com PRESS RELEASESSeed Therapeutics has completed construction of a new state of the art innovation and research …See details»
SEED Therapeutics (SEED) Enters into Strategic Research …
Aug 6, 2024 SEED Concurrently Enters into Share Purchase Agreements for its Series A-3 Financing Led by EisaiThe SEED-Eisai Research Collaboration leverages Eisai’s leading …See details»
SEED Therapeutics (SEED) Enters into Strategic ... - Markets Insider
Aug 6, 2024 The SEED-Eisai Research Collaboration leverages Eisai’s leading expertise in neurodegeneration and cancer. SEED is entitled to receive upfront and milestone payments of …See details»
BeyondSpring Subsidiary, Seed Therapeutics, Announces
Nov 13, 2020 To learn more about Seed Therapeutics, please visit us at seedtherapeutics.com. About BeyondSpring Headquartered in New York, BeyondSpring is a global, clinical-stage …See details»
SEED Therapeutics, BeyondSpring Subsidiary, Appoints Jackson Tai …
Jun 20, 2023 Former Director at Eli Lilly, HSBC and MastercardBrings Almost Five Decades of Experience in Finance, Strategy and Risk Governance NEW YORK, June 20, 2023 (GLOBE …See details»
BeyondSpring Subsidiary, Seed Therapeutics, Announces Research ...
Nov 13, 2020 To learn more about Seed Therapeutics, please visit us at seedtherapeutics.com. About BeyondSpring Headquartered in New York, BeyondSpring is a global, clinical-stage …See details»
Seed Therapeutics - Overview, News & Similar companies
Jun 20, 2023 Seed Therapeutics contact info: Phone number: (646) 859-2751 Website: www.seedtherapeutics.com What does Seed Therapeutics do? Seed Therapeutics, a …See details»
BeyondSpring Subsidiary, Seed Therapeutics, Announces Research ...
Nov 13, 2020 To learn more about Seed Therapeutics, please visit us at seedtherapeutics.com. About BeyondSpring Headquartered in New York, BeyondSpring is a global, clinical-stage …See details»
Seed Therapeutics blossoms in an $800M deal with Lilly
Nov 13, 2020 Seed Therapeutics Inc. signed a massive deal with Eli Lilly and Co. on Nov. 12, a date that resonated deeply with Seed’s CEO, Lan Huang. Twenty-one years earlier to the day …See details»
礼来与万春医药子公司Seed Therapeutics达成7.9亿美元泛素化靶向 …
Nov 13, 2020 总金额达到7.9亿美元，美国 礼来公司 与 万春医药 子公司万春Seed将借助自主研发的独特“分子胶”蛋白降解这一专利技术开发候选新药。 2020年11月12日，Seed …See details»
SEED Therapeutics Enters into Strategic Research Collaboration …
Aug 6, 2024 SEED Concurrently Enters into Share Purchase Agreements for its Series A-3 Financing Led by Eisai The SEED-Eisai Research Collaboration leverages Eisai’s leading …See details»